[Transvaginal sonography as a screening method for the identification of patients at risk of postmenopausal endometrial pathology]

Minerva ginecologica · 1993 · vol. 45(7-8) , pp. 339–42 · PMID:8414140 · W2416632689
Other OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-13 ⓘ

Transvaginal sonography effectively screens for postmenopausal endometrial pathology, demonstrating high reliability in identifying patients at risk of conditions like polyps and proliferative endometrium without false positives.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Starting from the anatomopathological assumption that endometrial thickness in postmenopausal women never exceeds 3 mm, and in view of the reliability of measurements made using an echographic probe, the authors evaluated the value of transvaginosonography (TVS) as a mass screening method for postmenopausal endometrial pathologies. A group of 74 patients were examined who were recruited from those attending the out-patient menopause clinic. All subjects conformed to the following admission criteria: amenorrhea for the past two years; absence of oestroprogestin therapy for at least six months; absence of vaginal blood loss. A 5 MHz probe was used to measure maximum endometrial thickness on the longitudinal plane; values were divided by two if the surfaces were adjacent. Patients were monitored according to the following protocol: endometrial thickness under 1 mm control every 12 months; thickness between 1-3 mm--control every 3 months; thickness equal to or over 4 mm--hysteroscopy, targeted biopsy, possible scraping and TVS control after 3 months. The group was subdivided as follows: 65 patients (87.8%) were without risk; 3 patients (4%) belonged to the intermediate risk group; 6 patients (8.2%) belonged to the high risk group. Of the latter, 4 revealed an endometrial polyp, one presented uterine polymyomatosis and one a proliferative-type endometrium. The authors' experience is still limited but the absence of false positives encourages them to continue their research using this simple and well tolerated method. It might represent a valid alternative to hysteroscopy as a screening method in the asymptomatic population at risk for endometrial carcinoma.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Hyperplasia Endometrial Neoplasms Endometrium Postmenopause Biopsy Diagnosis, Differential Endometrial Hyperplasia Endometrial Neoplasms Endometrium Endometrium Endometrium Female Humans Hysteroscopy Mass Screening Methods Middle Aged Risk Factors Ultrasonography Vagina

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:31.578486+00:00
License: CC0 · commercial use OK